We first set out to investigate the changes in expression levels and cellular sources of CHI3L1 in the context of NASH by using a murine model that recapitulates the features of advanced fibrotic human NASH. The gene discussed is CHI3L1; the disease is metabolic dysfunction-associated steatohepatitis.